The Irish Times

Shire sells cancer drugs to Servier for $2.4bn as Takeda circles

Divestment of the cancer business may be a deterrent for Takeda

Mon Apr 16 2018 - 10:36

Japanese drug kingpin Takeda mulling approach for Shire

Any deal would likely bid Irish rare disease specialist at close to €57bn

Wed Mar 28 2018 - 11:00

Pharma group Shire signs training deal for Dublin

Irish domiciled company to get ‘customised training programmes’ from universities

Mon Mar 26 2018 - 18:29

Shire may spin off ADHD drugs business

The pharma company upgrades guidance after strong first half

Thu Aug 03 2017 - 14:02

Dublin-based Shire Pharmaceuticals sees earnings rise 14%

Firm planning to create 150 new jobs in State reports product sales up 110% to $3.4bn

Tue May 02 2017 - 13:20

Shire receives planning permission for Co Meath plant

Dublin-headquartered pharma giant is creating 400 jobs as part of the investment

Tue Dec 06 2016 - 11:14

Shire shares surge as drug group upgrades earnings guidance

Irish-domiciled business says cost savings in $32bn Baxalta deal 40% more than expected

Tue Aug 02 2016 - 17:42

Perils of paying CEOs too much: When shareholders say no

Shareholders are rejecting proposals to ramp up CEOs’ rewards

Tue Apr 26 2016 - 06:00

Pharma group Shire to create 400 jobs in Co Meath

Republic a ‘strategically important location’ for the company

Fri Apr 15 2016 - 13:26

Cantillon: Shire takeover of Baxalta fails to impress shareholders

Shire shares slide 8% as analysts concerned about ambitious savings target from merger

Tue Jan 12 2016 - 07:30

Shire to buy Dyax for $5.9 bn

Deal will give Dublin-based pharma group access to treatment for inflammatory disease

Mon Nov 02 2015 - 13:18

Shire results beat forecasts as it still tracks Baxalta

CEO Flemming Ornskov refused to be drawn on whether drugmaker will pitch new higher offer

Fri Oct 23 2015 - 14:33

Shire seeks access to $30bn takeover target Baxalta’s books

Shire CEO confident Baxalta shareholders are open to a deal

Mon Aug 17 2015 - 01:00

Shire seen having to raise $30bn Baxalta bid

Investor says shareholders in Dublin company may back increase from current $45.23 a share offer to $50 but some unease over scale of acquisition

Mon Aug 10 2015 - 19:24

Shire beats analysts’ forecasts with first-quarter earnings

Dublin-based company wins more sales for drugs treating ADHD

Thu Apr 30 2015 - 15:59

Shire structure puts spotlight on tax

Drug firm has come out fighting after allegations it engaged in tax avoidance on an industrial scale

Tue Feb 17 2015 - 10:07

Dublin-headquartered Shire faces fresh scrutiny over tax

Questions on firm’s $1.6 billion “break fee” from AbbVie

Fri Feb 13 2015 - 14:01

Patent win helps Shire as AbbVie plots next bid move

London-listed pharma company has already spurned a $46 billion takover offer from US firm

Wed Jun 25 2014 - 09:38

Shire worth more than Abbvie bid, says CEO

Product sales will increase at a double-digit rate with expansion in drugs for rare diseases

Tue Jun 24 2014 - 00:50

Generic competition pushes Sanofi to 34% fall in first-quarter profit

Rival Shire misses estimates amid increased competition

Thu May 02 2013 - 20:52